Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

FULFARO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.880
EU - Europa 3.642
AS - Asia 1.002
AF - Africa 22
OC - Oceania 11
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.572
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.874
IT - Italia 874
UA - Ucraina 809
CN - Cina 635
FI - Finlandia 571
DE - Germania 406
IE - Irlanda 276
SG - Singapore 203
GB - Regno Unito 189
SE - Svezia 162
FR - Francia 115
RU - Federazione Russa 99
KR - Corea 43
BE - Belgio 32
IN - India 32
RO - Romania 27
TR - Turchia 26
CI - Costa d'Avorio 21
IR - Iran 15
CH - Svizzera 14
PL - Polonia 14
HK - Hong Kong 13
NL - Olanda 12
UZ - Uzbekistan 12
GR - Grecia 11
AU - Australia 9
AT - Austria 7
BR - Brasile 5
ES - Italia 5
EU - Europa 5
BG - Bulgaria 3
CA - Canada 3
CY - Cipro 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
LB - Libano 3
MX - Messico 3
NP - Nepal 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
IQ - Iraq 2
JP - Giappone 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PE - Perù 2
AR - Argentina 1
BN - Brunei Darussalam 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
TH - Thailandia 1
TW - Taiwan 1
VN - Vietnam 1
Totale 12.572
Salva come PNG Salva come JPEG
Città #
Fairfield 1.195
Woodbridge 684
Ashburn 676
Chandler 620
Wilmington 522
Houston 494
Seattle 445
Jacksonville 430
Ann Arbor 387
Cambridge 330
Dublin 270
Medford 225
Nanjing 175
Singapore 148
Princeton 142
Des Moines 123
Palermo 121
Tulsa 108
Altamura 101
Boardman 91
Lawrence 82
Ludwigshafen am Rhein 77
San Diego 73
Beijing 69
Dearborn 59
Milan 55
New York 55
Nanchang 53
Shenyang 48
Changsha 43
Seongnam 42
Hebei 40
Tianjin 35
Brussels 32
Jinan 28
Santa Clara 27
Jiaxing 26
London 25
Los Angeles 23
Abidjan 21
Kitzingen 21
Izmir 20
Falls Church 19
Rome 19
Saint Petersburg 19
Berlin 17
Helsinki 17
Kumar 17
San Mateo 17
Verona 16
Zhengzhou 15
Guangzhou 14
Bremen 13
San Paolo di Civitate 13
Kunming 12
Orange 11
Auburn Hills 10
Hangzhou 10
Kraków 10
Norwalk 10
Central District 9
Chicago 9
Düsseldorf 9
Ningbo 9
Springfield 9
Taiyuan 9
Tehran 9
Philadelphia 8
Phoenix 8
Taizhou 8
Lanzhou 7
Venice 7
Washington 7
Moscow 6
Pune 6
Catania 5
Città Di Castello 5
Forest City 5
Melbourne 5
Munich 5
Reggio Calabria 5
Den Haag 4
Edinburgh 4
Frankfurt Am Main 4
Hong Kong 4
Leawood 4
Pinerolo 4
Redwood City 4
San Francisco 4
Amsterdam 3
Athens 3
Atlanta 3
Augusta 3
Dallas 3
Frankfurt am Main 3
Fuzhou 3
Genoa 3
Haikou 3
Hanover 3
Kathmandu 3
Totale 8.715
Salva come PNG Salva come JPEG
Nome #
Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study 308
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 202
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 191
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 191
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 187
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 169
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): run dental management designs and issues in diagnosis. 168
Γ δ T Cell-Based Immunotherapy in Melanoma: State of the Art 159
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 158
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 156
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 155
Surgical Treatment of Extravasation Injuries 153
Clinical presentation and treatment of gastrointestinal stromal tumors. 153
A prospective randomized study of corticosteroids as adjuvant drugs to opioids in advanced cancer patients 146
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 146
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 146
Serum follistatin in patients with prostate cancer metastatic to the bone 145
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. 144
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report 142
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 141
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 139
The use of corticosteroids in home palliative care 136
Treatment strategies for cancer patients with breakthrough pain. 135
World Health Organization guidelines for cancer pain: a reappraisal 133
Low morphine doses in opioid-naive cancer patients with pain. 125
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 125
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. 124
A case of squamocellular uterine cervix carcinoma metastatic to the skin with enterocutaneous fistula. 123
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 123
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 123
Management of painful bone metastases 122
Carcinoma squamocellulare del pene localmente avanzato: associazione tra risposta clinica e modificazione dei livelli di ferritina sierica. 122
Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion 120
Isolated Metachronous Splenic Metastasis from Colon Cancer: Possible Explanations for This Rare Entity 117
Factors involved in gastrointestinal bleeding in advanced cancer patients followed at home 116
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients 116
LINEE GUIDA AIOM Trattamento e Prevenzione della Cachessia Neoplastica 115
Investigation of an opioid response categorization in advanced cancer patients 115
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? 112
Opioid responsiveness-primary diagnosis relationship in advanced cancer patients followed at home 108
The use of pilocarpine in opioid-induced xerostomia 108
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 107
Bortezomib: a new pro-apoptotic agent in cancer treatment. 106
Minor hepatic resection using heat coagulative necrosis. 105
Indagine sulla qualità di vita ansia e depressione in un gruppo di pazienti affette da carcinoma mammario 104
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway 104
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients 102
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 101
USE OF HERBAL REMEDIES AMONG CANCER AND TRANSPLANT PATIENTS IN THE TOWN OF PALERMO, SICILY 100
The course of symptom frequency and intensity in advanced cancer patients followed at home 100
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. 99
The impact of home palliative care on symptoms in advanced cancer patients 99
Gastrointestinal bleeding in advanced cancer patients 96
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 95
Factors influencing the opioid response in advanced cancer patients with pain followed at home: The effects of age and gender 95
Role of pamidronate disodium in the treatment of metastatic bone disease 94
A phase II study of Oxaliplatin Capecitabine chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 92
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. 91
The role of bisphosphonates in the treatment of painful metastatic bone disease: A review of phase III trials 91
Complicanze orali in pazienti affetti da carcinoma del cavo orale e sottoposti a radio e chemioterapia. Mucositi e xerostomia 90
Studio di phase II: Docetaxel settimanale come seconda linea chemioterapia nel carcinoma prostatico avanzato. 90
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 89
null 87
Detection and clinical relevance of free circulating tumor DNA in blood of patients with gastrointestinal cancer 84
Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis 84
Weekly paclitaxel and Pegylated liposomal doxorubicin as first line treatment in metastatic breast cancer patients 84
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 84
Opioid plasma concentration during switching from morphine to methadone: Preliminary data 84
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 82
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma 82
A randomized phase II study of estramustine phosphate versus estramustine phosphate plus etoposide in hormone refractory prostate cancer (HRPC). 81
The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer. 80
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a Phase II study. 79
Use of herbal products among cancer and transplanted patients in the town of Palermo,Sicily. 79
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 79
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation 78
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 77
Cardiotossicità e Cardioprotezione. 77
BRIAN DE PALMA 77
Effective use of a sodium-hyaluronate spray formulation in oral mucositis 75
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4) 75
A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: Effects on dose-escalation and a pharmacoeconomic analysis 72
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer 71
A case report of inflammatory pseudotumor of the liver 71
Utilizzo dell’octreotide nell’epatocarcinoma: case report e review della letteratura. 70
Relationship between thymidylate synthase expression and p53 levels with the treatment of cyclophosphamide, methotrexate, 5-fluorouracil chemotherapy(CMF) versus docetaxel (TXT) in locally advanced carcinoma of the breast. 68
Autoimmunity predicts prolonged survival in colon cancer patients undergoing GOLFIG biochemotherapy. 68
Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients. 68
REBECCA LA PRIMA MOGLIE di Alfred Hitchcock 67
The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results 67
Pain mechanisms involved and outcome in advanced cancer patients with possible indications for celiac plexus block and superior hypogastric plexus block 67
Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment † 66
Pattern of drug use by advanced cancer patients followed at home 64
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 64
Zoledronic acid-induced variations in MMP-2, MMP-9 and uPA plasma concentrations in patients with metastatic bone disease 63
L'ANNO SCORSO A MARIENBAD di Alain Resnais 63
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. 63
PROFESSIONE REPORTER di Michelangelo Antonioni 62
2001 Odissea nello Spazio 61
Fattori predittivi di risposta ai citostatici nei tumori del tratto gastrointestinale. In A Zaniboni “ I tumori del tratto gastroenterico” pag 31-37, Masson Editore, Milano, 2004 60
Totale 10.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.506 0 0 0 260 365 394 371 215 350 187 220 144
2020/20212.060 81 182 361 170 177 83 162 101 224 116 189 214
2021/20221.479 50 406 23 37 52 50 83 57 215 157 86 263
2022/20231.749 206 284 18 195 228 294 100 139 157 17 92 19
2023/2024878 56 136 64 53 76 150 129 39 15 12 14 134
2024/2025293 52 133 88 20 0 0 0 0 0 0 0 0
Totale 12.920